Ziltivekimab

Novo Nordisk to test anti-obesity molecule in t...

Novo Nordisk

China OKs Novo Nordisk's Type-2 diabetes treatm...

Novo Nordisk experience big profit rise due to ...

Novo Nordisk Logo Png

Novo Nordisk hits all-time high as oral obesity...

NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...

First: Novo Nordisk India launches oral Semaglu...

FID prosigue su larga colaboración con Novo Nor...

Novo Nordisk's results are stunning - and it co...

Novo Nordisk launches once-a-week diabetes drug...

Is Novo Nordisk Stock a Buy After its Collapse?...

Signal: Novo Nordisk market cap higher than Dan...

Novo Nordisk Research Centre opens in Oxford | ...

Novo Nordisk leaps on new obesity drug data | p...

Novo Nordisk - la compañia que trata la diabete...

Novo Nordisk receives FDA approval for Wegovy™

Novo Nordisk amplía sus fármacos contra la obes...

Novo Nordisk’s Global Commitment to Diabetes Ca...

Novartis' Sandoz dips on debut after lower than...

Novo Nordisk Posts Record Growth as Demand For ...

Novo Nordisk A/S Sees Unusually Large Options V...

Novo Nordisk Logo Png

Novo Nordisk

Novo Nordisk submits diabetes pill for US approval